BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6656770)

  • 1. Species-specific inhibition by glycophorins of complement activation via the alternative pathway.
    Okada H; Tanaka H
    Mol Immunol; 1983 Nov; 20(11):1233-6. PubMed ID: 6656770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of glycophorin of complement activation via the alternative pathway.
    Okada N; Yasuda T; Tsumita T; Shinomiya H; Utsumi S; Okada H
    Biochem Biophys Res Commun; 1982 Sep; 108(2):770-5. PubMed ID: 7150322
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of complement activation on the homologous cell membrane of nucleated cells as well as erythrocytes.
    Okada H; Tanaka H; Okada N
    Eur J Immunol; 1983 Apr; 13(4):340-4. PubMed ID: 6221932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro inhibition of the classical pathway of human complement by a natural microbial product, colistin sulphate.
    Asghar SS; de Koster A; van der Helm HJ
    Biochem Pharmacol; 1986 Sep; 35(17):2917-21. PubMed ID: 3638137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated alternative complement pathway activation resists inhibition by sialoglycolipids.
    Okada N; Yasuda T; Okada H
    J Immunol; 1985 May; 134(5):3316-9. PubMed ID: 2580023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of factor H by heparin: a rate-limiting mechanism for inhibition of the alternative complement pathway.
    Boackle RJ; Caughman GB; Vesely J; Medgyesi G; Fudenberg HH
    Mol Immunol; 1983 Nov; 20(11):1157-64. PubMed ID: 6228720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of desialated guinea pig erythrocytes with the classical and alternative pathways of guinea pig complement in vivo and in vitro.
    Brown EJ; Joiner KA; Frank MM
    J Clin Invest; 1983 Jun; 71(6):1710-9. PubMed ID: 6863540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the alternative pathway of human complement in vitro by a natural microbial product, complestatin.
    Kaneko I; Fearon DT; Austen KF
    J Immunol; 1980 Mar; 124(3):1194-8. PubMed ID: 6898640
    [No Abstract]   [Full Text] [Related]  

  • 9. Natural hemolytic and bactericidal activities of sea bream Sparus aurata serum are effected by the alternative complement pathway.
    Sunyer JO; Tort L
    Vet Immunol Immunopathol; 1995 Apr; 45(3-4):333-45. PubMed ID: 7676614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative study of erythrocytes from 4 animal species in the determination of hemolytic activity in classical and alternative pathways of bovine complement].
    Boulard C; Bencharif F
    Comp Immunol Microbiol Infect Dis; 1984; 7(1):27-34. PubMed ID: 6744811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the classical and alternative pathways of human and guinea pig complement by pyran copolymer.
    Webster GF; McArthur WP
    Int Arch Allergy Appl Immunol; 1981; 66(3):304-9. PubMed ID: 6913544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the alternative pathway of human complement by the extracellular slime glycolipoprotein of Pseudomonas aeruginosa.
    Lambris J; Papamichail M; Ioannidis C; Dimitracopoulos G
    J Infect Dis; 1982 Jan; 145(1):78-82. PubMed ID: 6798132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of C3 and consumption of hemolytic complement by extracts of airborne grain dust.
    Olenchock SA; Mull JC; Major PC
    Chest; 1979 Feb; 75(2 Suppl):225-7. PubMed ID: 108049
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemolysis by the complement of tanned erythrocytes coated with cobra venom factor: a sensitive method to detect the alternative complement pathway activity of serum.
    Okada H; Tanaka H
    J Immunol Methods; 1981; 46(1):85-95. PubMed ID: 6793665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of alternative pathway of complement activity in mouse serum using rabbit erythrocytes.
    Van Dijk H; Rademaker PM; Willers JM
    J Immunol Methods; 1980; 36(1):29-39. PubMed ID: 7204994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incompatibility between complement components C3 and C5 of guinea-pig and man, an indication of their interaction in C5 activation by classical and alternative C5 convertases.
    Von Zabern I; Nolte R; Vogt W
    Scand J Immunol; 1979; 9(1):69-74. PubMed ID: 419365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restriction of alternative complement pathway activation by sialosylglycolipids.
    Okada N; Yasuda T; Okada H
    Nature; 1982 Sep; 299(5880):261-3. PubMed ID: 7110347
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of a streptococcal preparation on the complement system.
    Kato H; Yokoe N; Matsumura N; Nishida K; Ikezaki M; Hosokawa K; Hotta T; Takemura S; Yoshikawa T; Kondo M
    Jpn J Exp Med; 1979 Oct; 49(5):343-50. PubMed ID: 529490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substances that can trigger activation of the alternative pathway of complement have anti-melanoma activity in mice.
    Cooper PD; Sim RB
    Int J Cancer; 1984 May; 33(5):683-7. PubMed ID: 6724743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K
    Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.